MK-7145

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Heart FailureHypertensionRenal ImpairmentRenal Insufficiency

Phase 1

A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)

CompletedNCT01370655

Merck Sharp & Dohme LLCHypertension

Start: 2011-06-15End: 2012-01-26Updated: 2018-09-21

A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)

TerminatedNCT01558674

Merck Sharp & Dohme LLCHeart Failure, Renal Impairment

Start: 2014-05-23End: 2014-12-17Updated: 2018-09-21

The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)

WithdrawnNCT01832103

Merck Sharp & Dohme LLCRenal Insufficiency

Start: 2013-08-31End: 2013-12-31Updated: 2013-09-24